PRK is the first and only enterprise in China to obtain both the registration certificate of the State Drug Administration (CFDA) and the military registration certificate.
In 2020, the joint developed product 2019-nCov RT-PCR- Fluorescence Probing passed the ministry expert assessment and exclusively obtained the registration Certificate of Special Provisions for drugs in the People’s Liberation Amy. (Military Drug Standard Q2020001)
President Xi inspecting PRK products at the Academy of Military Medical Sciences in March 2020. (Seen on CCTV news)
This kit is used to detect 2019-Novel Coronavirus RNA in the samples by adopting Real-Time PCR-Fluorescence technology, including targeting N protein of 2019-Novel Coronavirus, designing specific primers and probes and then detecting the fluorescence signals.
PRK supplies to the Chinese People's Liberation Army General Hospital where its facility is catered specially to the leaders of the CPC Central Committee, the Central Military Commission, the PLA General Headquarters, and to the troops stationed in Beijing.
PRK supplies to the largest infectious diseases hospital in China, the Chinese People's Liberation Army General Hospital where its facility is focused on Infectious Diseases research and treatment.